Scientific BPA - cder nextgen regulatory review analytics labor hour contract
Ended Awarded Last action
- Contract number
- 75F40123F19005
- Awardee
-
Deloitte Consulting LLP UEI CKV2L9GZKJK3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $4,596,521
Award facts
- Opportunity
-
- FDARFCOP02242023 Solicitation number
- Contract value 100% obligated
- $4,596,521.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541512 Computer Systems Design Services
- PSC
- R699 Support- Administrative: Other
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$103 | |
| Original award | $4,596,624 |
About this award
Deloitte Consulting LLP was awarded a labor hour Blanket Purchase Agreement (BPA) call valued at $4.6 million by the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) for NextGen Regulatory Review Analytics services. The contract, effective June 27, 2023, with an ultimate completion date of June 27, 2024, will be performed in Silver Spring, Maryland, and represents a task order against Deloitte's broader Master Schedule contract vehicle. This engagement supports the FDA's modernization of its drug regulatory review processes through advanced analytics capabilities, enabling the agency to enhance decision-making and operational efficiency in evaluating pharmaceutical submissions and post-market safety data.
As a large business contractor, Deloitte was not subject to small business set-aside requirements and was selected to deliver specialized analytical support services to support CDER's regulatory mission. The award reflects Deloitte's established expertise in providing data analytics and business intelligence services to federal health agencies, including prior engagements with the FDA on mission-critical initiatives. Deloitte's substantial federal contracting presence, including its $999.99 billion OASIS+ Unrestricted Indefinite Delivery/Indefinite Quantity vehicle and numerous agency-specific BPAs, demonstrates the firm's capacity to mobilize resources and execute complex federal engagements across diverse civilian and defense portfolios.
Quick answers
Who was awarded contract 75F40123F19005?
75F40123F19005 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on June 27, 2023.
How much is contract 75F40123F19005 worth?
The government has obligated $4,596,521 on 75F40123F19005.
Is contract 75F40123F19005 an order under another contract?
Yes. 75F40123F19005 is a BPA call under GS35F0617Y-75F40122A00001, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19005 competed?
The extent of competition for 75F40123F19005 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award